voice search
Rubraca 300mg Tablet - 60 Tablets, Oral Dosage | Parp Inhibitor For Advanced Ovarian Cancer, Targeted Therapy With Improved Survival

Rubraca 300mg Tablet - 60 Tablets, Oral Dosage | Parp Inhibitor For Advanced Ovarian Cancer, Targeted Therapy With Improved Survival

Get Latest Price

In Stock

In Stock

Product Specifications

Dosage300mg
FeaturesCancer treatment, PARP inhibitor, Ovarian cancer, Targeted therapy, Improved survival
FormTablet
PackagingBottle
Quantity60 tablets
RouteOral

Product Overview

Key Features

We are trusted Exporter and Distributor of Rubraca 300mg Tablets in Palghar, Maharashtra, India. Rubraca (rucaparib) is a poly (ADP-ribose) polymerase (PARP) inhibitor.

Rubraca is specifically indicated as monotherapy for the treatment of patients with deleterious BRCA mutation (germline and/or somatic) associated advanced ovarian cancer who have been treated with two or more chemotherapies. Patients should be selected for therapy based on an FDA-approved companion diagnostic for Rubraca.

Company Details

company name: Maxheal Pharmaceutical Pvt Limited contact person: Jiten Aggarwal Address: H.301 Maxheal house, tarapur industrial area, Dist Palghar 401506, Maharashtra.

Business Type

Exporter, Distributor

Employee Count

100

Establishment

1987

Working Days

To

Payment Mode

Western Union

Related Products

Explore Related Categories

More Products From This Seller

Seller Details

Palghar, Maharashtra

Seller Inquiry

Accepts only Foreign inquiries

Name

Jiten Aggarwal

Address

Address: H.301 Maxheal house, tarapur industrial area, Dist. Palghar, Maharashtra, 401506, India

life saving drug in Palghar

Report incorrect details

Compare With Similar Products

People Also Viewed